Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Radiology Nuclear Medicine and imaging
Reference29 articles.
1. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708);Kato;Jpn J Clin Oncol,2009
2. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906);Kato;Int J Radiat Oncol Biol Phys,2011
3. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus;Ohtsu;J Clin Oncol,1999
4. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer;Miyata;J Surg Oncol,2009
5. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy;Swisher;J Thorac Cardiovasc Surg,2002
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Importance of early detection of esophageal cancer before the tumor progresses too much for effective treatment;World Journal of Gastrointestinal Oncology;2024-08-15
2. Transvascular delivery of talaporfin sodium to subcutaneous tumors in mice by nanosecond pulsed laser-induced photomechanical waves;Photodiagnosis and Photodynamic Therapy;2023-12
3. Management of Cancer using Photodynamic Therapy: Advancement and Applications;Current Cancer Therapy Reviews;2023-10-11
4. The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy;Frontiers in Bioengineering and Biotechnology;2023-10-02
5. Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial;Radiation Oncology;2023-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3